Digest Network Come funziona
Network
/
Società
Ne
Non verificato

Neuromod Devices

Di cosa scriviamo

BiologiaEconomiaFarmaceuticaMediaSanità

6 comunicati stampa

Guarda tutti i comunicati
Press Release cover image
16/10/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Lenire Now Included in U.S. ENT Clinical Practice Guidelines - First New Treatment Added by American Academy of Otolaryngology Since Establishment of the Academy's Tinnitus Guidelines
Fonte
Neuromod Devices
Emittente
PR News Wire
1.00
0
28/04/2025
Farmaceutica
Sanità
Scienza
Biologia
Nature Communications Medicine Publishes Positive, Real World Data for Tinnitus Patients Treated with Unique, FDA Approved Stimulation Device
Fonte
Neuromod Devices
Emittente
PR News Wire
1.00
0
Press Release cover image
15/10/2024
Farmaceutica
Sanità
Efficacia di Lenire dispositivo per il trattamento degli acufeni dimostrata in uno studio clinico controllato
Fonte
Neuromod Devices
Emittente
PR News Wire
1.00
0
Press Release cover image
20/08/2024
Farmaceutica
Sanità
Controlled Clinical Trial Results for FDA-Approved Tinnitus Treatment Device Lenire Published in Nature Communications
Fonte
Neuromod Devices
Emittente
PR News Wire
1.00
0
Press Release cover image
03/07/2024
Farmaceutica
Sanità
Economia
Management
Organizzazione Aziendale
Biologia
Neuromod Devices Ltd. Appoints Tom Maher as General Counsel
Fonte
Neuromod Devices
Emittente
PR News Wire
1.00
0
Press Release cover image
17/06/2024
Farmaceutica
Sanità
Economia
Start-up
Neuromod's FDA-Approved Lenire Device Now a Treatment Option for 2.9 Million US Veterans with Tinnitus
Fonte
Neuromod Devices
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0